Melanie McCullagh, D.Phil, MBA
Director of Business Development
Melanie McCullagh joined Biotica as Business Development Director in April 2008. She was previously at Antisoma, where she was instrumental in the 2007 licensing of ASA404 to Novartis in a deal worth $890m, and was involved in establishing the Roche collaboration in 2002. She was also responsible for bringing new investigational cancer drugs into the company through in-licensing and collaborations, and for company strategic analysis. Prior to Antisoma, Melanie led the Strategy Analysis group in Datamonitor Healthcare, providing insight to leading pharmaceutical and biotechnology clients into areas such as forecasting, licensing, M&A and portfolio management. Melanie has an MA from Cambridge University, a D.Phil from Oxford University and an MBA from London Business School.
